S. Hanauer

Genetics · 2000–2016

A researcher in the Science corpus: 24 papers; trusts 4 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom S. Hanauer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Sandborn
  2. A. Neish

Who trusts S. Hanauer overall

  1. W. Sandborn
  2. Markus F. Neurath
  3. Stefan Schreiber
  4. G. Lichtenstein
  5. S. Ben-Horin
  6. Q. Guan
  7. Daniel C. Baumgart
  8. J. Colombel
  9. B. Feagan

Papers from S. Hanauer's perspective

Ordered by how strongly the researchers S. Hanauer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. (Gastroenterology)
  2. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. (Gastroenterology)
  3. The immunological and genetic basis of inflammatory bowel disease (Nature reviews. Immunology)
  4. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. (Gastroenterology)
  5. Placebo Effects: Biological, Clinical and Ethical Advances (The Lancet)
  6. Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* (Journal of Biological Chemistry)
  7. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans (Nature Genetics)
  8. A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 (Inflammatory Bowel Diseases)
  9. Inflammatory bowel disease: clinical aspects and established and evolving therapies (The Lancet)
  10. Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination

Their papers